Writing to inform

I have been working on a piece about hormone replacement therapy. How distressing to learn that once again  the FDA has abandoned its obligation to protect the consumer and not the manufacturers. In this case, the pharmaceutical companies.  Presently, there is a strident campaign against bio-identical hormone replacement therapy. The basis for this campaign is the billions of dollars at stake for the pharmaceutical companies. 

The is a place in medicine for more than one treatment. It seems more than reasonable to me that women should have the option to choose whether they want and need to take synthetically created hormones or bio-identical hormones. The science for bio-identical hormones is available. Unfortunately, the issue will only become moot when the pharmaceutical industry has figured out how to create bio-identical therapies that they can patent.